Overall, we can conclude that while inducing anti-tumour-associated Cd40 and Cd80 and reducing pro-tumorigenic VISTA, SFV also upregulated PD-L1 which could interfere with the therapeutic effect. This evidence concerns the gene CD80 and neoplasm.